CSIMarket


Orchard Therapeutics Plc  (ORTX)
Other Ticker:  
 

Orchard Therapeutics Plc

ORTX's Fundamental analysis








Looking into Orchard Therapeutics Plc growth rates, revenue grew by 9.09 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 1194

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -7.98 %

Orchard Therapeutics Plc net loss deacreased by in III. Quarter 2023 year on year, Orchard Therapeutics Plc net loss increased by -25.75 % in III. Quarter 2023 year on year,

More on ORTX's Growth


Orchard Therapeutics Plc
realized net loss in trailing twelve months.

Orchard Therapeutics Plc realized cash outflow of $ -0.25per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 174.65.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.68.


More on ORTX's Valuation
 
 Total Debt (Millions $) 26
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 3.61
 Tangible Book Value (Per Share $) 0.34

Orchard Therapeutics Plc
realized net loss in trailing twelve months.

Orchard Therapeutics Plc realized cash outflow of $ -0.25per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 174.65.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.68.

Orchard Therapeutics Plc Price to Book Ratio is at 47.52 lower than Indusry Avg. of 873.55. and higher than S&P 500 Avg. of -2057.92

More on ORTX's Valuation

  Market Capitalization (Millions $) 3,814
  Shares Outstanding (Millions) 228
  Employees -
  Revenues (TTM) (Millions $) 22
  Net Income (TTM) (Millions $) -73
  Cash Flow (TTM) (Millions $) -57
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) 26
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 3.61
  Tangible Book Value (Per Share $) 0.34

  Market Capitalization (Millions $) 3,814
  Shares Outstanding (Millions) 228
  Employees -
  Revenues (TTM) (Millions $) 22
  Net Income (TTM) (Millions $) -73
  Cash Flow (TTM) (Millions $) -57
  Capital Exp. (TTM) (Millions $) -1





  Ratio
   Capital Ratio (MRQ) 3.12
  Total Debt to Equity (MRQ) 0.32
  Tangible Leverage Ratio (MRQ) 1.59
  Asset Turnover Ratio (TTM) 0.11
  Inventory Turnover Ratio (TTM) 1.98





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com